/ pharma stocks
/ Market Analysis
Moderna Slashes R&D Budget, Stock Plummets Amid Profitability Concerns
Moderna announced plans to slash its R&D budget by $1.1 billion by 2027.
September 12, 2024
Big Pharma Stocks: Who’s Leading the Race and Who’s Slipping?
Merck's wider drug moat and acquisition spree makes it a safer bet but VKTX can be the next LLY.
August 20, 2024
Eli Lilly Enters the Chinese Market as Tirzepatide Gains Approval, Shares Gain
Eli Lilly's weight loss drug tirzepatide has received approval from Chinese regulators, intensifying competition with Novo Nordisk.
July 19, 2024
Wall Street Weighs in as Pfizer Targets $100 Billion Weight Loss Market
Pfizer announced plans to advance a once-daily version of its weight loss pill, danuglipron, following encouraging early-stage trial results.
July 11, 2024
LLY vs NVO: Which One is Likely to Become a $1T Company First
Tackling growing waistlines is expected to yield much shareholder value.
February 08, 2024
Back to 
